Sanofi Collaboration Drives Lexicon Pharma's (LXRX) 4Q Success; Wedbush Raises Price Target to $28

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. FND
9. DASH
10. GILD

Go back to Sanofi Collaboration Drives Lexicon Pharma's (LXRX) 4Q Success; Wedbush Raises Price Target to $28

Lexicon Pharma (LXRX) Reports Q4 EPS of $0.76

March 1, 2016 7:11 AM EST

Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.76, versus ($0.03) reported last year. Revenue for the quarter came in at $127.3 million, versus $21.5 million reported last year.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More

Trading Radar for 3/1: AutoZone (AZO), Dollar Tree (DLTR), Donaldson (DCI), TiVo (TIVO), Veeva (VEEV) Report

February 29, 2016 2:16 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:

Earnings:

Ares Commercial Real Estate (NYSE: ACRE) - consensus EPS $0.27
AutoZone (NYSE: AZO) - consensus EPS $7.28
Bank of Nova Scotia (NYSE: BNS) - consensus EPS $1.42
Concert Pharma (Nasdaq: CNCE) - consensus loss $0.05
Del Frisco's (Nasdaq: DFRG) - consensus EPS $0.36
Diana... More